Fluphenazine levels during maintenance treatment of recent-onset schizophrenia: relation to side effects, psychosocial function and depression (original ) (raw )Fluphenazine decanoate in acute and maintenance therapy of schizophrenia
Massimo Carlo Mauri
Progress in Neuro-Psychopharmacology and Biological Psychiatry, 1987
View PDFchevron_right
Fluphenazine decanoate dose and severity of depression in patients with post-psychotic depression
Samuel Siris
Schizophrenia Research, 1988
View PDFchevron_right
Outpatient Maintenance of Chronic Schizophrenic Patients with Long-acting Fluphenazine: Double-blind Placebo
Steven Hirsch
BMJ, 1973
View PDFchevron_right
Fluphenazine plasma level monitoring for patients receiving fluphenazine decanoate
Jim Mintz
Schizophrenia Research, 2002
View PDFchevron_right
Flupwenazine Decanoate in Acute and ~Ainten~Ce Therapy of Schizop~K~Nia
Massimo Carlo Mauri
1987
View PDFchevron_right
Depressive and extrapyramidal symptoms and clinical effects: a trial of fluphenazine versus flupenthixol in maintenance of schizophrenic out- patients
Steven Hirsch
The British Journal of Psychiatry, 1979
View PDFchevron_right
Treatment of acute schizophrenia with ultra-high-dose fluphenazine: A failure at shortening time on a crisis-intervention unit
Donald Klein
Comprehensive Psychiatry, 1975
View PDFchevron_right
Oral fluphenazine versus placebo for schizophrenia: a Cochrane systematic review of 40 years of randomised controlled trials
Muhammad Almerie
Revista Colombiana De Psiquiatria, 2007
View PDFchevron_right
Fluphenazine decanoate: a clinical problem?
Rich Lewine
American Journal of Psychiatry, 1989
View PDFchevron_right
Double-blind, randomized comparison of olanzapine versus fluphenazine in the long-term treatment of schizophrenia
Ljubomir Hotujac
Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2004
View PDFchevron_right
Depot fluphenazine and flupenthixol in the treatment of stabilized schizophrenics. A double-blind comparative trial
Carlos Chacon
Comprehensive Psychiatry, 1980
View PDFchevron_right
Fluphenazine decanoate (timing of administration) for people with schizophrenia
Aisha Aljojo
Cochrane Database of Systematic Reviews, 2017
View PDFchevron_right
Efficacy of flupentixol and risperidone in chronic schizophrenia with predominantly negative symptoms
Stephan Ruhrmann
Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2007
View PDFchevron_right
Comparative bioavailability of two tablet formulations of fluphenazine dihydrochloride in drug-free psychiatric patients
Mohammad Al-Yamani
Journal of Pharmaceutical Sciences, 1990
View PDFchevron_right
Fluphenazine decanoate (depot) and enanthate for schizophrenia
Nicola Maayan
The Cochrane database of systematic reviews, 2015
View PDFchevron_right
Comparative effectiveness of fluphenazine decanoate injections every 2 weeks versus every 6 weeks
Ann Summerfelt
The American journal of psychiatry, 1999
View PDFchevron_right
Treatment of schizophrenia with depot preparations of fluphenazine, haloperidol, and risperidone among inpatients at state-operated psychiatric facilities
LESLIE CITROME
Schizophrenia Research, 2010
View PDFchevron_right
Risperidone, Quetiapine, and Fluphenazine in the Treatment of Patients With Therapy-Refractory Schizophrenia
Marie Mackowick -MDH-
Clinical Neuropharmacology, 2005
View PDFchevron_right
Fluphenazine decanoate (timing of administration) for people with schizophrenia (protocol)
Nawras Alhalabi , Aisha Aljojo , Tawfik Rajab
Fluphenazine decanoate (timing of administration) for people with schizophrenia (protocol), 2017
View PDFchevron_right
Comparison Of Effect Of Addition Of Fluvoxamine Or Risperidone To Clozapine In Chronic Partially Responsive Schizophrenic Patients On Clinical Response, QTc interval And Lipid profile
Praveer Waradkar
International Journal of Pharmacological Research, 2016
View PDFchevron_right
Depression in schizophrenia: Comparison of first- and second-generation antipsychotic drugs
Massimo Carlo Mauri
Schizophrenia Research, 2008
View PDFchevron_right
Effectiveness of antipsychotic drugs in patients with chronic schizophrenia
Karla Davila Soler
… England Journal of …, 2005
View PDFchevron_right
Impact of Second-Generation Antipsychotics and Perphenazine on Depressive Symptoms in a Randomized Trial of Treatment for Chronic Schizophrenia
Somaia Mohamed
The Journal of Clinical Psychiatry, 2010
View PDFchevron_right
Comparison of Polypharmacy in Schizophrenia and Other Psychotic Disorders in Outpatient and Inpatient Treatment Periods: A Naturalistic One Year Follow-up Study
hasan karadag
View PDFchevron_right
Clinical and Biologic Response to Clozapine in Patients With Schizophrenia Crossover Comparison With Fluphenazine
P. Konicki
View PDFchevron_right
Time-Dependent Clearance Decrements of Fluvoxamine in Depressed Inpatients
Walter van den Broek
Journal of Clinical Psychopharmacology, 2007
View PDFchevron_right
Depot fluphenazine decanoate and enanthate for schizophrenia (Review
Maurice Eisenbruch
View PDFchevron_right
The effects of olanzapine and fluphenazine on plasma cortisol, prolactin and muscle rigidity in schizophrenic patients: a double blind study
N. Pivac
Progress in Neuro- …, 2007
View PDFchevron_right